|
1
|
Harris JB, LaRocque RC, Qadri F, et al:
Cholera. Lancet. 379:2466–2476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leung DT, Chowdhury F, Calderwood SB, et
al: Immune responses to cholera in children. Expert Rev Anti Infect
Ther. 10:435–444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harris AM, Bhuiyan MS, Chowdhury F, et al:
Antigen-specific memory B-cell responses to Vibrio cholerae
O1 infection in Bangladesh. Infect Immun. 77:3850–3856. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qadri F1, Chowdhury MI, Faruque SM, et al:
Peru-15, a live attenuated oral cholera vaccine, is safe and
immunogenic in Bangladeshi toddlers and infants. Vaccine.
25:231–238. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trach DD, Cam PD, Ke NT, et al:
Investigations into the safety and immunogenicity of a killed oral
cholera vaccine developed in Viet Nam. Bull World Health Organ.
80:2–8. 2002.PubMed/NCBI
|
|
6
|
Davis BM, Moyer KE, Boyd EF and Waldor MK:
CTX prophages in classical biotype Vibrio cholerae:
functional phage genes but dysfunctional phage genomes. J
Bacteriol. 182:6992–6998. 2000.PubMed/NCBI
|
|
7
|
Simon R, Priefer U and Pühler A: A broad
host range mobilization system for in vivo genetic engineering:
transposon mutagenesis in Gram-negative bacteria. Nat Biotechnol.
1:784–791. 1983. View Article : Google Scholar
|
|
8
|
Philippe N, Alcaraz JP, Coursange E,
Geiselmann J and Schneider D: Improvement of pCVD442, a suicide
plasmid for gene allele exchange in bacteria. Plasmid. 51:246–255.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin W, Fullner KJ, Clayton R, et al:
Identification of a vibrio cholerae RTX toxin gene cluster
that is tightly linked to the cholera toxin prophage. Proc Natl
Acad Sci USA. 96:1071–1076. 1999.
|
|
10
|
Smithies O, Gregg RG, Boggs SS, et al:
Insertion of DNA sequences into the human chromosomal beta-globin
locus by homologous recombination. Nature. 317:230–234. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fullner KJ and Mekalanos JJ: In vivo
covalent cross-linking of cellular actin by the Vibrio
cholerae RTX toxin. EMBO J. 19:5315–5323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boardman BK, Meehan BM and Fullner
Satchell KJ: Growth phase regulation of Vibrio cholerae RTX
toxin export. J Bacteriol. 189:1827–1835. 2007. View Article : Google Scholar
|
|
13
|
Karaolis DK, Somara S, Manevel DR Jr, et
al: A bacteriophage encoding a pathogenicity island, a type-IV
pilus and a phage receptor in cholera bacteria. Nature.
399:375–379. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chattopadhyay K and Banerjee KK: Unfolding
of Vibrio cholerae hemolysin induces oligomerization of the
toxin monomer. J Biol Chem. 278:38470–38475. 2003.PubMed/NCBI
|
|
15
|
Karunasagar I, Rivera I, Joseph B, Kennedy
B, Shetty VR, Huq A, Karunasagar I and Colwell RR: ompU genes in
non-toxigenic Vibrio cholerae associated with aquaculture. J
Appl Microbiol. 95:338–343. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Olivier V, Haines GK III, Tan Y and
Satchell KJ: Hemolysin and the multifunctional autoprocessing RTX
toxin are virulence factors during intestinal infection of mice
with Vibrio cholerae El Tor O1 strains. Infect Immun.
75:5035–5042. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang W, Wang S, Yu F, Zhang L, Qi G, Liu
Y, Gao S and Kan B: Construction and evaluation of a safe, live,
oral Vibrio cholerae vaccine candidate, IEM108. Infect
Immun. 71:5498–5504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spangler BD: Structure and function of
cholera toxin and the related Escherichia coli heat-labile
enterotoxin. Microbiol Rev. 56:622–647. 1992.PubMed/NCBI
|
|
19
|
Pearson GD, Woods A, Chiang SL and
Mekalanos JJ: CTX genetic element encodes a site-specific
recombination system and an intestinal colonization factor. Proc
Natl Acad Sci USA. 90:3750–3754. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kimsey HH and Waldor MK: CTXphi immunity:
application in the development of cholera vaccines. Proc Natl Acad
Sci USA. 95:7035–7039. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan M, Liu G, Diao B, Qiu H, Zhang L,
Liang W, Gao S and Kan B: A Vibrio cholerae serogroup O1
vaccine candidate against CTX ET Phi infection. Vaccine.
25:4046–4055. 2007.PubMed/NCBI
|
|
22
|
Ledón T, Ferrán B, Pérez C, Suzarte E,
Vichi J, Marrero K, Oliva R and Fando R: TLP01, an mshA mutant of
Vibrio cholerae O139 as vaccine candidate against cholera.
Microbes Infect. 14:968–978. 2012.PubMed/NCBI
|
